Media coverage about Intermolecular (NASDAQ:IMI) has been trending somewhat positive on Wednesday, according to Accern Sentiment Analysis. The research firm scores the sentiment of media coverage by monitoring more than 20 million blog and news sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores closest to one being the most favorable. Intermolecular earned a daily sentiment score of 0.20 on Accern’s scale. Accern also gave headlines about the semiconductor company an impact score of 44.971168542144 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the company’s share price in the next few days.
Intermolecular (IMI) opened at 1.17 on Wednesday. Intermolecular has a 1-year low of $0.78 and a 1-year high of $1.20. The company’s 50-day moving average is $1.05 and its 200 day moving average is $0.94. The stock’s market capitalization is $57.98 million.
Separately, ValuEngine raised shares of Intermolecular from a “strong sell” rating to a “sell” rating in a research note on Monday, August 7th.
In related news, major shareholder Lloyd I. Miller III acquired 34,109 shares of Intermolecular stock in a transaction on Friday, September 1st. The stock was bought at an average cost of $0.86 per share, for a total transaction of $29,333.74. Following the completion of the transaction, the insider now owns 70,368 shares of the company’s stock, valued at approximately $60,516.48. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Insiders have acquired 38,930 shares of company stock valued at $33,480 over the last 90 days. 45.40% of the stock is currently owned by company insiders.
Intermolecular Company Profile
Intermolecular, Inc provides thin film solutions. The Company’s high productivity combinatorial (HPC) platform, which consists of its tempus processing tools, its automated characterization methods, and its Informatics analysis software, is purpose-built for research and development (R&D) using combinatorial process systems.
What are top analysts saying about Intermolecular Inc.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Intermolecular Inc. and related companies.